Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Stocks in news: TCS, Groww, Shriram Finance, Dixon Tech, Anand Rathi Wealth
Indian markets saw a rebound on Thursday, recovering from Wednesday's sharp sell-off. TCS reported a 5% year-on-year profit growth, and Groww affirmed its direct mutual fund strategy. Shriram Finance is raising funds to reduce borrowing costs after a rating upgrade. Maruti Suzuki plans to add service points, and Dixon Tech will expand smartphone manufacturing. Premier Energies commissioned a solar module facility, and Anand Rathi Wealth saw profit rise.
Stocks to Watch today: TCS, Tata Steel, GMR Airports, M&M, SBI, HFCL & more
Stocks to watch today: TCS, SBI, Tata Steel, GMR Airports, M&M, HFCL, RIL, Fortis Healthcare, JSW Infra, Swiggy, Pidilite, Shree Cement, among others, will be in focus today
Himadri Speciality among 4 stocks that closed below VWAP
Four Nifty 500 stocks closed over 1.5% below their VWAP on July 7, signalling potential selling pressure, according to StockEdge's technical scan.
Stocks to Watch for July 8: Cochin Shipyard, RCF, Uno Minda and more
From RCF board approving a fund raise up to ₹1,500 crore via FPO to Advait Energy Transitions securing a ₹51.62 crore turnkey contract, these are some stocks to track ahead of Wednesday trading session.
Sumitomo Chemical among 4 stocks that closed crossing below VWAP
Four Nifty500 stocks, Zydus Wellness, Sumitomo Chemical India, Max Healthcare Institute, and Zensar Technologies, closed over 1.5% below their VWAP on July 6, indicating potential bearish momentum and increased selling pressure, according to technical scan data.
Silent winners! 43 stocks turned multibaggers even as Nifty went nowhere in 2 years
Despite the Nifty 50 showing minimal returns over two years, astute investors have witnessed significant wealth creation. Forty-three stocks have more than doubled investor wealth, with companies in defence, healthcare, and specialty chemicals leading the charge. This period highlights that market opportunities often lie beneath the surface of headline index movements, rewarding patient stock pickers.
Nifty trades above 24,150; European mrkt advance
At 13:30 ST, the barometer index, the S&P BSE Sensex, soared 500.44 points or 0.65% to 77,512.65. The Nifty 50 index rose 153.95 points or 0.64% to 24,178.10.
Worst is behind us, markets could hit new highs in 6-12 months: Envision’s Nilesh Shah
Nilesh Shah, Founder of Envision Capital, remains positive on digital platforms, defence, aerospace and consumer discretionary sectors, citing long-term domestic growth drivers. Shah expects stronger earnings, policy reforms and foreign investor participation to support markets, while also identifying opportunities linked to GLP-1 drugs, nutrition products and healthcare themes.
Trust MF CIO sees revival in corporate cycle, stays bullish on mid and smallcaps
Mihir Vora, Chief Investment Officer at Trust Mutual Fund, remains bullish on renewable energy, with a preference for solar, and is betting on transmission and distribution companies as well as commercial clean energy suppliers catering to sectors such as data centres.
IKIGAI's Pankaj Tibrewal says opportunities now lie beyond the Nifty
IKIGAI Asset Manager's Pankaj Tibrewal sees a weaker rupee boosting India's export competitiveness, creating opportunities across auto parts, engineering, chemicals, textiles and electronics manufacturing.
Fortis Healthcare among 3 stocks with Golden Crossover; how to trade?
Nishchal Jain of Share.Market believes that the 'Golden Crossover' suggests the beginning of a multi-quarter recovery cycle for Fortis Healthcare, Deepak Fertilisers and Deepak Nitrite.
Indian cancer patients battle shortage of key drugs as platinum costs surge
Cancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues are causing shortages. This forces patients to search extensively for medication. Some drugmakers have reduced production. The situation puts immense pressure on the healthcare system and patients seeking treatment.